Salinosporamides D-J from the marine actinomycete Salinispora tropica, bromosalinosporamide, and thioester derivatives are potent inhibitors of the 20S proteasome

被引:76
作者
Reed, Katherine A. [1 ]
Manam, Rama Rao [1 ]
Mitchell, Scott S. [1 ]
Xu, Jianlin [1 ]
Teisan, Sy [1 ]
Chao, Ta-Hsiang [1 ]
Deyanat-Yazdi, Gordafaried [1 ]
Neuteboom, Saskia T. C. [1 ]
Lam, Kin S. [1 ]
Potts, Barbara C. M. [1 ]
机构
[1] Nereus Pharmaceut Inc, San Diego, CA 92121 USA
来源
JOURNAL OF NATURAL PRODUCTS | 2007年 / 70卷 / 02期
关键词
D O I
10.1021/np0603471
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Salinosporamide A (NPI-0052; 3), a highly potent inhibitor of the 20S proteasome, is currently in phase I clinical trials for the treatment of cancer. During the course of purifying multigram quantities of 3 from Salinispora tropica fermentation extracts, several new salinosporamides were isolated and characterized, most of which represent modifications to the chloroethyl substituent at C-2. Specifically, 3 was isolated along with the known compound salinosporamide B (4), the previously undescribed methyl congener salinosporamide D 7), and C-2 epimers of 3 and 7 (salinosporamides F (9) and G (10), respectively). Salinosporamide I (13), in which the methyl group at the ring junction is replaced with an ethyl group, and the C-5 deshydroxyl analogue salinosporamide J (14), were also identified. Replacement of synthetic sea salt with sodium bromide in the fermentation media produced bromosalinosporamide (12), 4, and its C-2 epimer (11, salinosporamide H). In addition to these eight new salinosporamides, several thioester derivatives were generated semisynthetically. IC50 values for cytotoxicity against human multiple myeloma cell line RPMI 8226 and inhibition of the chymotrypsin-like (CT-L) activity of purified rabbit 20S proteasomes were determined for all compounds. The results indicate that thioesters may directly inhibit the proteasome, albeit with reduced potency compared to their beta-lactone counterparts.
引用
收藏
页码:269 / 276
页数:8
相关论文
共 22 条
[1]  
ADAMS J, 2004, PROTEASOME INHIBITOR
[2]   Belactosin A, a novel antitumor antibiotic acting on cyclin/CDK mediated cell cycle regulation, produced by Streptomyces sp. [J].
Asai, A ;
Hasegawa, A ;
Ochiai, K ;
Yamashita, Y ;
Mizukami, T .
JOURNAL OF ANTIBIOTICS, 2000, 53 (01) :81-83
[3]  
Dick LR, 1997, J BIOL CHEM, V272, P182
[4]   Mechanistic studies on the inactivation of the proteasome by lactacystin A central role for clasto-lactacystin beta-lactone [J].
Dick, LR ;
Cruikshank, AA ;
Grenier, L ;
Melandri, FD ;
Nunes, SL ;
Stein, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (13) :7273-7276
[5]   Salinosporamide A:: A highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora [J].
Feling, RH ;
Buchanan, GO ;
Mincer, TJ ;
Kauffman, CA ;
Jensen, PR ;
Fenical, W .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (03) :355-+
[6]   A BETA-LACTONE RELATED TO LACTACYSTIN INDUCES NEURITE OUTGROWTH IN A NEUROBLASTOMA CELL-LINE AND INHIBITS CELL-CYCLE PROGRESSION IN AN OSTEOSARCOMA CELL-LINE [J].
FENTEANY, G ;
STANDAERT, RF ;
REICHARD, GA ;
COREY, EJ ;
SCHREIBER, SL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :3358-3362
[7]   Crystal structures of salinosporamide A (NPI-0052) and B (NPI-0047) in complex with the 20S proteasome reveal important consequences of β-lactone ring opening and a mechanism for irreversible binding [J].
Groll, M ;
Huber, R ;
Potts, BCM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (15) :5136-5141
[8]   Structure of 20S proteasome from yeast at 2.4 angstrom resolution [J].
Groll, M ;
Ditzel, L ;
Lowe, J ;
Stock, D ;
Bochtler, M ;
Bartunik, HD ;
Huber, R .
NATURE, 1997, 386 (6624) :463-471
[9]   Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach [J].
Groll, M ;
Huber, R .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2004, 1695 (1-3) :33-44
[10]   EPOXOMICIN, A NEW ANTITUMOR AGENT OF MICROBIAL ORIGIN [J].
HANADA, M ;
SUGAWARA, K ;
KANETA, K ;
TODA, S ;
NISHIYAMA, Y ;
TOMITA, K ;
YAMAMOTO, H ;
KONISHI, M ;
OKI, T .
JOURNAL OF ANTIBIOTICS, 1992, 45 (11) :1746-1752